Learning Objectives:

  • Learning Objective 1:Analyze updated data on the use of anti-tnf inhibitors in the last year.
  • Learning Objective 2:Gain knowledge on newly approved anti-tnf inhibitors in IBD.
Session date: 
11/01/2022 - 4:30pm to 5:30pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Joel Pekow